SCHEMBL8547895

SCHEMBL8547895

Brc1cccc(-c2cc(C3CCN(CCc4cccc5ccccc45)CC3)n[nH]2)c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.45
HTR1A P08908 1/20 0.45
DRD2 P14416 6/20 0.42
DRD4 P21917 6/20 0.42
DRD3 P35462 3/20 0.42
MC4R P32245 1/20 0.41
SIGMAR1 Q99720 3/20 0.40
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SNCA P37840 1/20 0.38
ADRA1D P25100 2/20 0.38
ADRA1A P35348 2/20 0.38
ADRA1B P35368 2/20 0.38
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
OPRL1 P41146 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8549889 0.88 SLC6A4 (0.44) SLC6A4HTR1ADRD2DRD4DRD3
SCHEMBL8547917 0.86 USP30 (0.41) SLC6A4HTR1ADRD2DRD4DRD3
SCHEMBL8549271 0.86 DRD2 (0.42) SLC6A4HTR1ADRD2DRD4DRD3
SCHEMBL8549897 0.86 DRD2 (0.52) SLC6A4HTR1ADRD2DRD4DRD3
SCHEMBL8548112 0.85 DRD4 (0.59) DRD2DRD4DRD3
SCHEMBL8545477 0.84 LMNA (0.43) SLC6A4HTR1ADRD2DRD4DRD3
SCHEMBL8546423 0.84 SNCA (0.42) SLC6A4HTR1ADRD2DRD4DRD3
SCHEMBL8549123 0.84 DRD2 (0.42) SLC6A4HTR1ADRD2DRD4DRD3
SCHEMBL8545434 0.83 DRD2 (0.40) SLC6A4HTR1ADRD2DRD4DRD3
SCHEMBL8550715 0.83 HTR1A (0.47) SLC6A4HTR1ADRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP claimed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP claimed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO claimed
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP disclosed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP disclosed
US-5668148-A BENIGN PROSTATIC HYPERTROPHY MERCK & CO., INC. (US) 1997-09-16 US disclosed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO disclosed